# VAP System Design

High-level operational architecture and semantic infrastructure doctrine for the Variant Annotation Pipeline (VAP).

---

# Overview

The Variant Annotation Pipeline (VAP) is a deterministic multi-stage genomic evidence processing system designed to transform raw sequencing payloads into progressively governed semantic interpretation substrates.

VAP increasingly emphasizes:

* semantic decomposition,
* deterministic routing,
* provenance continuity,
* bounded reviewability,
* interoperability-oriented substrate generation,
* and telemetry-aware operational governance.

Rather than functioning solely as a conventional annotation pipeline, VAP increasingly operates as:

```text
semantic infrastructure for governed biological evidence transformation.
```

---

# Core Architectural Philosophy

VAP is built around several guiding principles:

| Principle                        | Description                                                                         |
| -------------------------------- | ----------------------------------------------------------------------------------- |
| Deterministic decomposition      | progressively transform large evidence surfaces into reviewable semantic partitions |
| Provenance continuity            | preserve operational lineage across stage transitions                               |
| Semantic governance              | constrain ambiguity through explicit routing and interpretation layers              |
| Bounded reviewability            | reduce interpretive overload while preserving evidence fidelity                     |
| Manifest-oriented orchestration  | coordinate workflows through lightweight reproducible control surfaces              |
| Interoperability-oriented design | generate reusable downstream semantic substrates                                    |
| Payload/control-plane separation | separate large biological payloads from lightweight orchestration infrastructure    |

Together, these principles increasingly shape VAP into a governed semantic infrastructure system rather than a simple sequential pipeline.

---

# Operational Philosophy

VAP is intentionally designed around the observation that modern genomic workflows frequently encounter:

* excessive interpretive breadth,
* unstable reviewability surfaces,
* annotation inflation,
* provenance discontinuity,
* and interoperability fragmentation.

The pipeline therefore emphasizes:

```text
structured semantic reduction rather than uncontrolled evidence accumulation.
```

This reduction is not merely filtering.

Instead, VAP progressively:

* partitions,
* contextualizes,
* annotates,
* validates,
* and routes

evidence into increasingly reviewable semantic substrates.

---

# High-Level Execution Flow

## Foundational Processing

Stages 01–06 perform foundational sequencing operations:

| Stage | Purpose            |
| ----- | ------------------ |
| 01    | raw data ingestion |
| 02    | alignment          |
| 03    | BAM processing     |
| 04    | alignment QC       |
| 05    | variant calling    |
| 06    | VCF normalization  |

These stages primarily transform sequencing payloads into normalized variant evidence surfaces.

---

## Semantic Annotation Layer

Stage 07 performs large-scale annotation enrichment.

This layer integrates:

* VEP annotations,
* ClinVar assertions,
* population-frequency annotations,
* transcript-level consequence information,
* and variant-context metadata.

The resulting substrate becomes the primary semantic evidence surface for downstream governance workflows.

---

## Semantic Partitioning Layer

Stage 08 performs one of the most important transformations within VAP.

Rather than aggressively filtering evidence away, the pipeline performs:

```text
governed semantic decomposition.
```

This stage partitions evidence into multiple interoperable semantic surfaces including:

* coding candidates,
* noncoding candidates,
* RDGP-oriented gene evidence,
* and variant-summary substrates.

This architecture preserves semantic continuity while reducing interpretive overload.

---

# Interpretation Architecture

VAP intentionally separates:

```text
coding interpretability
```

from:

```text
noncoding contextual uncertainty.
```

This distinction reflects differing biological evidence characteristics.

---

## Coding Interpretation

Coding evidence often supports:

* stronger deterministic reasoning,
* transcript-aware prioritization,
* ClinVar-supported escalation,
* and clearer functional interpretation surfaces.

Stages 09 and 11 therefore support progressively stronger prioritization workflows for coding substrates.

---

## Noncoding Interpretation

Noncoding evidence is intentionally treated more conservatively.

Rather than forcing deterministic pathogenic interpretation, VAP preserves:

* uncertainty,
* contextual ambiguity,
* and evidence lineage continuity.

This architecture avoids overstating biological certainty while still enabling meaningful contextualization and reviewability.

---

# Validation and Bounded Escalation

Stage 12 introduces validation-oriented governance surfaces.

This layer performs:

* QC-aware escalation,
* reliability assessment,
* artifact labeling,
* and validation continuity analysis.

Importantly, VAP increasingly emphasizes:

```text
bounded evidence escalation.
```

The system intentionally avoids uncontrolled prioritization inflation and instead constrains escalation through structured validation logic.

---

# Final Reporting Layer

Stage 13 consolidates:

* operational telemetry,
* semantic summaries,
* review-oriented outputs,
* and interoperability substrates.

This stage transforms the execution into portable downstream analytical surfaces suitable for:

* cross-run analysis,
* interoperability routing,
* reproducibility assessment,
* and future composable ecosystem workflows.

---

# Provenance Continuity

A central architectural principle throughout VAP is preservation of provenance continuity.

The system increasingly preserves:

* execution lineage,
* routing continuity,
* semantic ancestry,
* and operational telemetry

across stage transitions.

This architecture supports:

* reproducibility,
* auditability,
* interoperability,
* and downstream semantic governance.

---

# Payload-Plane vs Control-Plane Separation

VAP intentionally separates:

| Layer         | Description                                                                                         |
| ------------- | --------------------------------------------------------------------------------------------------- |
| Payload-plane | large genomic evidence artifacts such as FASTQs, BAMs, VCFs, and cohort-scale TSVs                  |
| Control-plane | lightweight orchestration manifests, telemetry, overlays, schemas, and semantic governance surfaces |

Large biological payloads remain external to repository version control.

The repository instead versions:

* manifests,
* schemas,
* telemetry,
* fixtures,
* interoperability substrates,
* and orchestration infrastructure.

This design improves:

* portability,
* reproducibility,
* and operational scalability.

---

# Manifest-Oriented Orchestration

Many VAP workflows are intentionally governed through lightweight manifest-oriented orchestration.

Examples include:

* cohort acquisition,
* Stage 12 analytical exports,
* lightweight transfer workflows,
* and cross-run analytical routing.

Rather than embedding execution topology directly into scripts, VAP increasingly externalizes orchestration into deterministic lightweight coordination surfaces.

This improves:

* reproducibility,
* transparency,
* portability,
* and semantic continuity.

---

# Telemetry-Aware Execution

VAP incorporates observability-oriented operational infrastructure including:

* runtime profiling,
* stage summaries,
* metadata emission,
* run fingerprints,
* execution telemetry,
* and validation-oriented monitoring surfaces.

This telemetry infrastructure enables:

* operational characterization,
* reproducibility assessment,
* cross-run comparison,
* and execution-governance analysis.

---

# Interoperability-Oriented Design

VAP increasingly generates reusable downstream semantic substrates intended to support interoperability across the broader repository ecosystem.

Representative downstream systems include:

* GSC,
* RDGP,
* VDB,
* and future analytical infrastructure layers.

This interoperability orientation influenced:

* Stage 08 semantic partitioning,
* overlay substrate generation,
* manifest-oriented orchestration,
* and downstream SQL-oriented analytical harvesting.

---

# Cross-Run Governance

Later VAP development increasingly emphasized cohort-scale operational analysis.

Cross-run workflows evaluated:

* semantic stability,
* provenance continuity,
* reviewability behavior,
* interoperability structure,
* and telemetry consistency

across heterogeneous sequencing contexts.

These analyses helped formalize many of the architectural concepts that now define the mature VAP ecosystem.

---

# Architectural Scope

VAP intentionally does not attempt to function as:

* a clinical diagnostic engine,
* a final pathogenicity authority,
* or a fully autonomous interpretation platform.

Instead, the system emphasizes:

```text
structured semantic evidence governance.
```

The goal is not maximal automated certainty.

The goal is reproducible, reviewable, and interoperable evidence transformation.

---

# Relationship to the Broader Ecosystem

VAP increasingly functions as one component within a broader semantic infrastructure ecosystem involving:

* VDB,
* GSC,
* RDGP,
* and future downstream analytical systems.

The pipeline therefore increasingly prioritizes:

* composability,
* semantic continuity,
* deterministic interoperability,
* and reusable substrate generation.

---

# Summary

VAP is a deterministic semantic infrastructure system designed to transform large genomic evidence payloads into progressively governed, reviewable, and interoperable semantic substrates.

The architecture emphasizes:

* semantic decomposition,
* provenance continuity,
* bounded escalation,
* manifest-oriented orchestration,
* interoperability-oriented design,
* and telemetry-aware operational governance

to support reproducible biological evidence transformation across complex analytical environments.
